Europe electrocardiograph (ECG) market was valued at $1,854.0 million in 2021 and will grow by 5.7% annually over 2021-2031, driven by the rising incidences of cardiac disorders and lifestyle related diseases, constantly increasing incidences of casualties due to cardiovascular diseases (CVDs), the increase in geriatric population coupled with behavioral risk factors such as rise in alcohol consumption and smoking, technological advancement and innovations, and the increasing healthcare e...
Asia Pacific electrocardiograph (ECG) market will grow by 8.2% annually with a total addressable market cap of $32,834.0 million over 2022-2031, driven by the rising incidences of cardiac disorders and lifestyle related diseases, constantly increasing incidences of casualties due to cardiovascular diseases (CVDs), the increase in geriatric population coupled with behavioral risk factors such as rise in alcohol consumption and smoking, technological advancement and innovations, and the inc...
Global active pharmaceutical ingredients market will reach $334 billion by 2028, growing by 6.9% annually over 2021-2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population. Highlighted with 146 tables and 104 figures, this 254-page report “Global Active Pharmaceutical Ingredients (API) Market 2021-2028 by Synthesis (Synthetic, Biotech, HPAPI),...
North America active pharmaceutical ingredients market is projected to grow by 5.3% annually in the forecast period and reach $111.44 billion by 2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population. Highlighted with 86 tables and 68 figures, this 193-page report “North America Active Pharmaceutical Ingredients (API) Market 2021-2028 by Syn...
Europe active pharmaceutical ingredients market was valued at $49.52 billion in 2021 and will grow by 7.3% annually over 2021-2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population. Highlighted with 95 tables and 69 figures, this 193-page report “Europe Active Pharmaceutical Ingredients (API) Market 2021-2028 by Synthesis (Synthetic, Biotech...
Asia Pacific active pharmaceutical ingredients market will grow by 8.8% annually with a total addressable market cap of $691.3 billion over 2021-2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population. Highlighted with 92 tables and 68 figures, this 192-page report “Asia Pacific Active Pharmaceutical Ingredients (API) Market 2021-2028 by Synth...
Global digital surgery technologies market will reach $3,661.7 mn by 2030, growing by 30.9% annually over 2021-2030, driven by burgeoning complexities in clinical decision-making and an increase in surgeon's workload, increasing R&D investments, and technological advancements in AI, IoT, big data, extended reality (ER), and digitalization. Highlighted with 84 tables and 92 figures, this 174-page report “Global Digital Surgery Technologies Market 2021-2030 by Offering, Product Type (Na...
North America digital surgery technologies market is projected to grow by 30.1% annually in the forecast period and reach $2,133.3 million by 2030, driven by burgeoning complexities in clinical decision-making and an increase in surgeon's workload, increasing R&D investments, and technological advancements in AI, IoT, big data, extended reality (ER), and digitalization. Highlighted with 25 tables and 56 figures, this 110-page report “North America Digital Surgery Technologies Market 2...
Europe digital surgery technologies market was valued at $79.9 million in 2021 and will grow by 30.8% annually over 2021-2030, driven by burgeoning complexities in clinical decision-making and an increase in surgeon's workload, increasing R&D investments, and technological advancements in AI, IoT, big data, extended reality (ER), and digitalization. Highlighted with 35 tables and 60 figures, this 118-page report “Europe Digital Surgery Technologies Market 2021-2030 by Offering, Produc...
Asia Pacific digital surgery technologies market will grow by 35.8% annually with a total addressable market cap of $2,168.9 million over 2021-2030, driven by burgeoning complexities in clinical decision-making and an increase in surgeon's workload, increasing R&D investments, and technological advancements in AI, IoT, big data, extended reality (ER), and digitalization. Highlighted with 32 tables and 59 figures, this 118-page report “Asia Pacific Digital Surgery Technologies Market 2...
